...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith-Oncology Pipeline

narmac,

"at least we have some sort of business plan going in Zenith,, unlike RVX,,but most likely only because professionals BPs are involved!!"

What business plan do you see happening with Zenith that it's not much of the same that is ongoing with RVX? If a business plan is for others to get you over the finish line, is not much of a business plan. A business needs to stand on its own two feet and that takes money. Don seems to gamble his way through. That may work some of the time as long as you don't paint yourself into a corner. 

 

 

Koo

 

Share
New Message
Please login to post a reply